Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -3.186\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) O=[N+]([O-])c1ccccc1-c1nc(-c2ccc(Br)o2)no1
b.) COc1ccc(-c2ccc(O[C@@H]3OC(C)(C)[C@H](OC)[C@@H](O)[C@H]3O)cc2C(=O)NCc2ccccc2)cc1
c.) CC1CN(C(=O)Cn2c(=O)oc3ccccc32)CC(C)O1
d.) CCC(C(=O)NCc1cccnc1)c1ccccc1
e.) Fc1ccc(-c2nc3c(-c4ccc(F)cc4)cnn3cc2CCN2CCOCC2)cc1
Answer: e. Fc1ccc(-c2nc3c(-c4ccc(F)cc4)cnn3cc2CCN2CCOCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Fc1ccc(-c2nc3c(-c4ccc(F)cc4)cnn3cc2CCN2CCOCC2)cc1
Fc1ccc(-c2nc3c(-c4ccc(F)cc4)cnn3cc2CCN2CCOCC2)cc1
4-[2-[3,5-bis(4-fluorophenyl)pyrazolo[1,5-a]pyrimidin-6-yl]ethyl]morpholine